Target intelligence / Profile preview

GRHL3 antisense RNA 1 (GRHL3-AS1)

Target: GRHL3-AS1
Molecular classification: Other (long noncoding RNA)

Overview

GRHL3 antisense RNA 1 (GRHL3-AS1) is a long noncoding RNA that maps antisense to the GRHL3 locus (NCBI Gene accession: 105376871, transcript NR_183722.1). Long noncoding RNAs frequently regulate the expression of adjacent protein-coding genes and may play roles in epigenetic control, transcriptional modulation, and cellular differentiation. Currently, no functional characterization, validated disease associations, or reports of drug interactions are available for GRHL3-AS1. The main biological and therapeutic literature focuses on the adjacent sense gene GRHL3, a transcription factor involved in barrier formation, wound repair, and tumor suppression, but these findings may not directly apply to GRHL3-AS1.

Other names: GRHL3 antisense RNA 1GRHL3-AS1

Mechanism of action

Not characterized.

Biological functions

The specific functions of GRHL3-AS1 remain largely uncharacterized. By analogy with other antisense lncRNAs, it may regulate expression of the sense gene (GRHL3), influence chromatin structure, or modulate transcription through RNA-RNA or RNA-protein interactions, but published data are limited.Other (possible gene regulation, epigenetic modulation)

Disease associations

There is currently no definitive evidence linking GRHL3-AS1 specifically to diseases. In contrast, **GRHL3** (the sense transcript) is well established as a tumor suppressor and regulator of differentiation with roles in skin, oral, and esophageal cancers. No disease associations for the antisense RNA are separately documented.

Safety considerations

None specific to GRHL3-AS1. Safety concerns around lncRNA targeting are mostly theoretical at this stage.

Interacting drugs

No drugs are described to directly interact with GRHL3-AS1. Some experimental investigation of lncRNAs as therapeutic targets exists, but not for this entity.

Biomarkers

No published biomarkers involving GRHL3-AS1 in patient selection or efficacy monitoring.

Beyond the preview

Go deeper on GRHL3 antisense RNA 1 (GRHL3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GRHL3 antisense RNA 1 (GRHL3-AS1).

Explore the full profile